Figure 1
Figure 1. miR-223 and NFI-A mRNA/protein levels in human hematopoietic cells and leukemias. (A) Quantitative RT-PCR of NFI-A mRNA level (□), Northern blot analysis of miR-223 expression, and immunodetection of NFI-A protein in CD34+ HSC/HPCs and CD34− cells from PB or BM. U6 and β-tubulin were probed as RNA and protein loading controls, respectively. (B) Quantitative RT-PCR of miR-223 (■) and NFI-A (□) mRNA expression levels in leukemia patient samples classified by FAB.24 ALL indicates acute lymphocytic leukemia; and NA, not available. Genetic features of leukemia blasts are indicated. Quantitative RT-PCR data are represented as mean ± SD of 3 independent evaluations.

miR-223 and NFI-A mRNA/protein levels in human hematopoietic cells and leukemias. (A) Quantitative RT-PCR of NFI-A mRNA level (□), Northern blot analysis of miR-223 expression, and immunodetection of NFI-A protein in CD34+ HSC/HPCs and CD34 cells from PB or BM. U6 and β-tubulin were probed as RNA and protein loading controls, respectively. (B) Quantitative RT-PCR of miR-223 (■) and NFI-A (□) mRNA expression levels in leukemia patient samples classified by FAB.24  ALL indicates acute lymphocytic leukemia; and NA, not available. Genetic features of leukemia blasts are indicated. Quantitative RT-PCR data are represented as mean ± SD of 3 independent evaluations.

Close Modal

or Create an Account

Close Modal
Close Modal